Gilead Sciences researches, develops, and commercializes medicines in areas of unmet medical need.
Explore more US and African stocks, read the latest market news, or compare African stock exchanges on Wallflake.
Gilead Sciences researches, develops, and commercializes medicines in areas of unmet medical need. Gilead Sciences operates in the Healthcare sector and trades on the NASDAQ under the ticker GILD.
Gilead Sciences is listed on the NASDAQ, where it trades under the ticker symbol GILD. It is classified in the Healthcare sector.
GILD last traded at USD 150.78 on 4 September 2026, down 0.29% on the session. Live prices for Gilead Sciences update through the trading day on Wallflake.
Gilead Sciences has a market capitalisation of approximately USD 186.96B, based on its closing price on 4 September 2026.
Over the past 52 weeks GILD has traded between a low of USD 108.46 and a high of USD 157.29.
Yes. Gilead Sciences pays a dividend, with a trailing yield of 2.19%. Its payout ratio is approximately 43.40%.
GILD has a price-to-earnings (P/E) ratio of 22.20 and earnings per share (EPS) of USD 6.78. These figures are reported metrics, not a valuation opinion — Wallflake does not issue buy, sell or hold recommendations.
GILD shares are bought and sold through a broker licensed to trade on the NASDAQ. You open an account with a licensed broker, fund it, and place an order quoting the ticker GILD. Wallflake is a market-data and research platform, not a broker, and does not execute trades or give investment advice. See our NASDAQ guide for how the market works. Read the guide
Figures are drawn from Wallflake's market data and are provided for information only. Nothing here is investment advice or a recommendation to buy or sell any security.